Ocugen Management
Management criteria checks 2/4
Ocugen's CEO is Shankar Musunuri, appointed in Sep 2019, has a tenure of 4.67 years. total yearly compensation is $7.66M, comprised of 9.3% salary and 90.7% bonuses, including company stock and options. directly owns 0.8% of the company’s shares, worth $2.71M. The average tenure of the management team and the board of directors is 1 years and 4.5 years respectively.
Key information
Shankar Musunuri
Chief executive officer
US$7.7m
Total compensation
CEO salary percentage | 9.3% |
CEO tenure | 4.7yrs |
CEO ownership | 0.8% |
Management average tenure | less than a year |
Board average tenure | 4.5yrs |
Recent management updates
Recent updates
Ocugen announces peer-reviewed publication on COVID-19 vaccine
Sep 14Ocugen initiated with Buy at Mizuho citing favorable setup ahead of key readout
Aug 23Ocugen Q2 2022 Earnings Preview
Aug 04Ocugen: A First Take
Jul 18Ocugen in renewed focus as FDA wants COVID boosters to fight Omicron variant
Jul 05Where Will Ocugen Stock Be In 5 Years?
Apr 27Ocugen: FDA Lifts Clinical Hold As Shares Sink - It May Be Worth Staying The Course
Feb 24Ocugen: The Life After COVID-19
Jan 23CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | -US$63m |
Sep 30 2023 | n/a | n/a | -US$76m |
Jun 30 2023 | n/a | n/a | -US$83m |
Mar 31 2023 | n/a | n/a | -US$80m |
Dec 31 2022 | US$8m | US$715k | -US$87m |
Sep 30 2022 | n/a | n/a | -US$74m |
Jun 30 2022 | n/a | n/a | -US$63m |
Mar 31 2022 | n/a | n/a | -US$69m |
Dec 31 2021 | US$8m | US$541k | -US$58m |
Sep 30 2021 | n/a | n/a | -US$48m |
Jun 30 2021 | n/a | n/a | -US$47m |
Mar 31 2021 | n/a | n/a | -US$38m |
Dec 31 2020 | US$2m | US$500k | -US$34m |
Jun 30 2020 | n/a | n/a | -US$30m |
Mar 31 2020 | n/a | n/a | -US$18m |
Dec 31 2019 | US$572k | US$420k | -US$20m |
Sep 30 2019 | n/a | n/a | -US$39m |
Jun 30 2019 | n/a | n/a | -US$18m |
Mar 31 2019 | n/a | n/a | -US$19m |
Dec 31 2018 | US$431k | US$420k | -US$18m |
Compensation vs Market: Shankar's total compensation ($USD7.66M) is above average for companies of similar size in the US market ($USD2.43M).
Compensation vs Earnings: Shankar's compensation has been consistent with company performance over the past year.
CEO
Shankar Musunuri (59 yo)
4.7yrs
Tenure
US$7,662,810
Compensation
Dr. Shankar Musunuri, Ph D., MBA, is the Co-Founder of Ocugen, Inc. and has been its Chairman and Chief Executive Officer and Director since September 27, 2019. He served as Interim Principal Financial Off...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 4.7yrs | US$7.66m | 0.80% $ 2.7m | |
Co-founder & Independent Director | no data | US$341.82k | 0.27% $ 930.7k | |
Interim Chief Accounting Officer & Corporate Controller | less than a year | no data | no data | |
Chief Scientific Officer and Head of Research & Development | 1.7yrs | no data | 0.041% $ 138.0k | |
General Counsel | no data | no data | no data | |
AVP & Head of Corporate Communications | no data | no data | no data | |
Head of People & Culture | less than a year | no data | no data | |
Senior Vice President of Commercial | 2.9yrs | no data | no data | |
VP & Head of Regulatory & Quality | 1.3yrs | no data | no data | |
Chief Medical Officer | less than a year | no data | 0.00064% $ 2.2k | |
VP, Head of Program Management & Chief of Staff | less than a year | no data | no data |
1.0yrs
Average Tenure
40yo
Average Age
Experienced Management: OCGN's management team is not considered experienced ( 1 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 4.7yrs | US$7.66m | 0.80% $ 2.7m | |
Co-founder & Independent Director | 4.7yrs | US$341.82k | 0.27% $ 930.7k | |
Lead Independent Director | 4.1yrs | US$357.60k | 0% $ 0 | |
Independent Director | 2.2yrs | US$649.56k | 0.00039% $ 1.3k | |
Member of Retina Scientific Advisory Board | 4.5yrs | no data | no data | |
Independent Director | 4.7yrs | US$347.28k | 0% $ 0 | |
Member of Retina Scientific Advisory Board | no data | no data | no data | |
Vaccine Scientific Advisory Board Member | 3.4yrs | no data | no data | |
Independent Director | 4.7yrs | US$335.56k | 0.45% $ 1.5m | |
Member of Retina Scientific Advisory Board | no data | no data | no data | |
Independent Director | 4.1yrs | US$348.18k | 0.019% $ 66.0k | |
Member of Retina Scientific Advisory Board | 4.5yrs | no data | no data |
4.5yrs
Average Tenure
59.5yo
Average Age
Experienced Board: OCGN's board of directors are considered experienced (4.5 years average tenure).